Combination antifungal therapy: A strategy for the management of invasive fungal infections

被引：0
|
作者：
Javier Carrillo-Munoz, Alfonso [1 ]
Finquelievich, Jorge [2 ]
Tur-Tur, Cristina [1 ]
Eraso, Elena [3 ]
Jauregizar, Nerea [4 ]
Quindos, Guillermo [3 ]
Giusiano, Gustavo [5 ]
机构：
[1] ACIA, Dept Microbiol, Barcelona, Spain
[2] Univ Buenos Aires, Fac Med, Ctr Micol, RA-1053 Buenos Aires, DF, Argentina
[3] Univ Basque Country, Fac Med & Odontol, Dept Inmunol Microbiol & Parasitol, E-48080 Bilbao, Spain
[4] Univ Basque Country, Fac Med & Odontol, Dept Farmacol, E-48080 Bilbao, Spain
[5] Univ Nacl Nordeste, Inst Med Reg, Dept Micol, Nordeste, Argentina
来源：
REVISTA ESPANOLA DE QUIMIOTERAPIA | 2014年 / 27卷 / 03期
关键词：
IN-VITRO INTERACTIONS; HUMAN RECOMBINANT ANTIBODY; AMPHOTERICIN-B; CANDIDA-ALBICANS; TIME-KILL; SYNERGISTIC INTERACTION; CALCINEURIN INHIBITORS; ASPERGILLUS-FUMIGATUS; TRIPLE COMBINATION; SYSTEMIC MYCOSES;
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：141 / 158
页数：18
相关论文
共 50 条
  • [41] Antifungal therapy for newborn infants with invasive fungal infection
    Clerihew, Linda
    McGuire, William
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (06):
  • [42] Advances in invasive fungal infection and antifungal therapy:: Introduction
    Denning, DW
    Muñoz, P
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 : VII - VII
  • [43] Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies
    Lorenz Grigull
    Andreas Beilken
    Hansjoerg Schmid
    P. Kirschner
    Karl-Walter Sykora
    Christin Linderkamp
    Frank Donnerstag
    Lilia Goudeva
    Hans-Gert Heuft
    Karl Welte
    [J]. Supportive Care in Cancer, 2006, 14 : 783 - 786
  • [44] Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies
    Grigull, Lorenz
    Beilken, Andreas
    Schmid, Hansjoerg
    Kirschner, P.
    Sykora, Karl-Walter
    Linderkamp, Christin
    Donnerstag, Frank
    Goudeva, Lilia
    Heuft, Hans-Gert
    Welte, Karl
    [J]. SUPPORTIVE CARE IN CANCER, 2006, 14 (07) : 783 - 786
  • [45] Laboratory diagnosis and therapy of invasive fungal infections
    Willinger, B
    [J]. CURRENT DRUG TARGETS, 2006, 7 (04) : 513 - 522
  • [46] Management of breakthrough invasive fungal infections (IFI)
    Maschmeyer, G.
    [J]. MYCOSES, 2013, 56 : 38 - 39
  • [47] Management of invasive fungal infections: a role for polyenes
    Chandrasekar, Pranatharthi
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (03) : 457 - 465
  • [48] Baseline antifungal usage patterns and knowledge regarding management of invasive fungal infections as a part of a multidisciplinary antifungal stewardship (AFS) program
    Sachdev, Janya
    Singh, Gagandeep
    Xess, Immaculata
    Soneja, Manish
    [J]. MEDICAL MYCOLOGY, 2022, 60 (SUPP 1) : 68 - 68
  • [49] Management of Invasive fungal infections in pediatric patient
    Groll, A.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2007, 37 : 12 - 13
  • [50] Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B
    van de Peppel, Robert J.
    Schauwvlieghe, Alexander
    Van Daele, Ruth
    Spriet, Isabel
    van't Wout, Jan W.
    Bruggemann, Roger J.
    Rijnders, Bart J. A.
    Hendriks, Bart J. C.
    de Boer, Mark G. J.
    [J]. MEDICAL MYCOLOGY, 2020, 58 (07) : 874 - 880
12345